Churakov Andrei

Dr. Churakov Andrei

Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2012 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
MVMikhail Vener
Mikhail Vener
AEA. N. Egorova
A. N. Egorova
Churakov AndreiChurakov Andrei
Churakov Andrei
VTVladimir G. Tsirelson
Vladimir G. Tsirelson

11 September 2014 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ASArtem Surov
Artem Surov
AVAlexander P. Voronin
Alexander P. Voronin
AMAlex Nikolaevich Manin
Alex Nikolaevich Manin
NMNikolay G. Manin
Nikolay G. Manin
LKLyudmila G. Kuzmina
Lyudmila G. Kuzmina
German PerlovichGerman Perlovich
German Perlovich

17 October 2011 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
MVMikhail Vener
Mikhail Vener
Alexander G. MedvedevAlexander G. Medvedev
Alexander G. Medvedev
Churakov AndreiChurakov Andrei
Churakov Andrei
PPPetr V. Prikhodchenko
Petr V. Prikhodchenko
TTTatiana A. Tripol’skaya
Tatiana A. Tripol’skaya
OLOvadia Lev
Ovadia Lev

2 December 2016 in Crystal Growth & Design
Verified
Journal Article
Closed access
ICIvan Chernyshov
Ivan Chernyshov
MVMikhail Vener
Mikhail Vener
PPPetr V. Prikhodchenko
Petr V. Prikhodchenko
Alexander G. MedvedevAlexander G. Medvedev
Alexander G. Medvedev
OLOvadia Lev
Ovadia Lev
Churakov AndreiChurakov Andrei
Churakov Andrei

23 June 2017 in CrystEngComm
Verified
Journal Article
Open access
PDF file
KDKsenia Drozd
Ksenia Drozd
AMAlex Nikolaevich Manin
Alex Nikolaevich Manin
Churakov AndreiChurakov Andrei
Churakov Andrei
German PerlovichGerman Perlovich
German Perlovich
The cocrystal formation of the anticonvulsant drug carbamazepine (CBZ) with para-aminosalicylic acid (PASA, antituberculous drug) has been studied by varying the molar ratios of CBZ to PASA (1 : 1 and 2 : 1) and using liquid-assisted grinding (LAG), slurrying and solution crystallization methods. Three novel cocrystal forms of CBZ and PASA have been synthesized: [CBZ + PASA] (1 : 1), [CBZ + PASA + H2O] (2 : 1 : 1) and [CBZ + PASA + MeOH] (2 : 1 : 1), and their crystal structures have been described. Conformational analysis of the CBZ molecule in its polymorphic forms, its cocrystals and solvates has been conducted. Calculations of intermolecular interaction energies using the PIXEL approach have been carried out for CBZ cocrystals with 1 : 1 stoichiometry. The melting and desolvation processes of the [CBZ + PASA] (1 : 1), [CBZ + PASA + H2O] (2 : 1 : 1) and [CBZ + PASA + MeOH] (2 : 1 : 1) cocrystals have been studied. The temperature dependence of the CBZ (form III) saturation vapor pressure has been studied, and the sublimation thermodynamic functions have been calculated. Based on the sublimation thermodynamics database of molecular crystals, the standard sublimation thermodynamic functions of PASA have been evaluated. The thermodynamic functions of cocrystal formation based on CBZ have been calculated and analyzed. The dissolution process of the [CBZ + PASA] cocrystal (1 : 1) in water (pH 7.4) has been studied. CBZ cocrystallization with PASA has been shown to lead to a dramatic decrease of the CBZ rate of conversion from the anhydrous to the hydrate form, and as a consequence, to solubility improvement by approximately 1.5 times.

1 September 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
ASArtem Surov
Artem Surov
AMAlex Nikolaevich Manin
Alex Nikolaevich Manin
AVAlexander P. Voronin
Alexander P. Voronin
KDKsenia Drozd
Ksenia Drozd
ASAnna A. Simagina
Anna A. Simagina
German PerlovichGerman Perlovich
German Perlovich